364 related articles for article (PubMed ID: 24970025)
1. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
Kim HS; Kim CK; Park BK; Huh SJ; Kim B
J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
[TBL] [Abstract][Full Text] [Related]
3. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
4. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Early Therapeutic Changes to Concurrent Chemoradiotherapy in Uterine Cervical Cancer Using Blood Oxygenation Level-Dependent Magnetic Resonance Imaging.
Choi SH; Kim CK; Park JJ; Park BK
J Comput Assist Tomogr; 2016; 40(5):730-4. PubMed ID: 27636125
[TBL] [Abstract][Full Text] [Related]
7. Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study.
Liu Y; Sun H; Bai R; Ye Z
Radiat Oncol; 2015 Sep; 10():185. PubMed ID: 26337954
[TBL] [Abstract][Full Text] [Related]
8. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
Kuang F; Yan Z; Wang J; Rao Z
Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
[TBL] [Abstract][Full Text] [Related]
9. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
Jeon TY; Kim CK; Kim JH; Im GH; Park BK; Lee JH
Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222
[TBL] [Abstract][Full Text] [Related]
10. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
12. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
15. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
Zhu L; Zhu L; Shi H; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Feb; 16():79. PubMed ID: 26860361
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
[TBL] [Abstract][Full Text] [Related]
17. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
[TBL] [Abstract][Full Text] [Related]
18. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
[TBL] [Abstract][Full Text] [Related]
19. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
20. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
